AbbVie, Inc. (ABBV)
256.42
+0.94
(+0.37%)
USD |
NYSE |
Aug 31, 16:00
257.00
+0.58
(+0.23%)
After-Hours: 20:00
AbbVie Total Long Term Debt (Quarterly) : 70.82B for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 70.82B |
| March 31, 2026 | 72.86B |
| December 31, 2025 | 65.69B |
| September 30, 2025 | 64.95B |
| June 30, 2025 | 64.92B |
| March 31, 2025 | 68.30B |
| December 31, 2024 | 67.84B |
| September 30, 2024 | 71.08B |
| June 30, 2024 | 70.63B |
| March 31, 2024 | 74.00B |
| December 31, 2023 | 60.12B |
| September 30, 2023 | 60.74B |
| June 30, 2023 | 61.02B |
| March 31, 2023 | 62.09B |
| December 31, 2022 | 64.02B |
| September 30, 2022 | 69.60B |
| June 30, 2022 | 72.92B |
| March 31, 2022 | 73.46B |
| December 31, 2021 | 77.38B |
| September 30, 2021 | 80.70B |
| June 30, 2021 | 82.12B |
| March 31, 2021 | 85.52B |
| December 31, 2020 | 86.85B |
| September 30, 2020 | 87.00B |
| June 30, 2020 | 87.37B |
| Date | Value |
|---|---|
| March 31, 2020 | 67.04B |
| December 31, 2019 | 66.98B |
| September 30, 2019 | 38.67B |
| June 30, 2019 | 37.24B |
| March 31, 2019 | 36.95B |
| December 31, 2018 | 36.61B |
| September 30, 2018 | 37.51B |
| June 30, 2018 | 33.60B |
| March 31, 2018 | 36.92B |
| December 31, 2017 | 36.97B |
| September 30, 2017 | 37.00B |
| June 30, 2017 | 36.84B |
| March 31, 2017 | 36.55B |
| December 31, 2016 | 36.46B |
| September 30, 2016 | 37.31B |
| June 30, 2016 | 37.35B |
| March 31, 2016 | 31.51B |
| December 31, 2015 | 31.26B |
| September 30, 2015 | 31.37B |
| June 30, 2015 | 31.12B |
| March 31, 2015 | 14.70B |
| December 31, 2014 | 14.59B |
| September 30, 2014 | 14.49B |
| June 30, 2014 | 14.49B |
| March 31, 2014 | 14.40B |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Biogen, Inc. | 8.355B |
| Gilead Sciences, Inc. | 26.25B |
| Regeneron Pharmaceuticals, Inc. | 2.707B |
| Amgen, Inc. | 57.30B |
| REGENXBIO, Inc. | 243.11M |